Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Porter’S Five Force Analysis
3.1.1. Threat Of New Entry
3.1.2. Threat Of Substitution
3.1.3. Buyer’S Power
3.1.4. Supplier’S Power
3.1.5. Competitive Rivalry
3.2. Regulatory Framework
3.3. Impact Of Covid-19 On Pharmaceutical Continuous Manufacturing Market
3.4. Opportunity Matrix
3.5. Vendor Landscape
3.6. Key Investment Insights

4. Market By Product
4.1. Integrated Continuous System
4.2. Semi-Continuous System
4.3. Control & Software

5. Market By Application
5.1. Final Drug Product Manufacturing
5.2. Api Manufacturing

6. Market By End-User
6.1. Pharmaceutical Companies
6.2. Contract Manufacturing Organizations
6.3. Other End-Users

7. Competitive Landscape
7.1. Key Strategic Developments
7.1.1. Merger & Acquisitions
7.1.2. Product Launch & Developments
7.1.3. Partnership, Contract/Agreement & Collaboration
7.1.4. Business Expansion/ Approval/ Announcement
7.2. Company Profiles
7.2.1. Munson Machinery Company
7.2.2. Pfizer Inc
7.2.3. Thermo Fisher Scientific Inc
7.2.4. Eli Lilly & Company
7.2.5. Siemens Healthineers



List of Figures


List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: United States Pharmaceutical Continuous Manufacturing Market, By Product, In 2020
Figure 6: United States Pharmaceutical Continuous Manufacturing Market, By Integrated Continuous System, 2021-2026 (In $ Million)
Figure 7: United States Pharmaceutical Continuous Manufacturing Market, By Semi-Continuous System, 2021-2026 (In $ Million)
Figure 8: United States Pharmaceutical Continuous Manufacturing Market, By Control & Software, 2021-2026 (In $ Million)
Figure 9: United States Pharmaceutical Continuous Manufacturing Market, By Application, In 2020
Figure 10: United States Pharmaceutical Continuous Manufacturing Market, By Final Drug Product Manufacturing, 2021-2026 (In $ Million)
Figure 11: United States Pharmaceutical Continuous Manufacturing Market, By Api Manufacturing, 2021-2026 (In $ Million)
Figure 12: United States Pharmaceutical Continuous Manufacturing Market, By End-User, In 2020
Figure 13: United States Pharmaceutical Continuous Manufacturing Market, By Pharmaceutical Companies, 2021-2026 (In $ Million)
Figure 14: United States Pharmaceutical Continuous Manufacturing Market, By Contract Manufacturing Organizations, 2021-2026 (In $ Million)
Figure 15: United States Pharmaceutical Continuous Manufacturing Market, By Other End-Users, 2021-2026 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL CONTINUOUS MANUFACTURING
TABLE 2: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)